GeneOne Life Science, Inc. (011000.KS)
KRW 2035.0
(-3.1%)
KRW 2035.0
(-3.1%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -21.74 Billion | -24.11 Billion | -4.84 Billion | -15.91 Billion | -1.27 Billion | -7.26 Billion |
| Net Income | -77.76 Billion | -38.15 Billion | -15.95 Billion | -18.64 Billion | -7.61 Billion | -11.89 Billion |
| Depreciation & Amortization | 12.77 Billion | 5.42 Billion | 4.63 Billion | 4.02 Billion | 3.42 Billion | 1.29 Billion |
| Deferred income taxes | - | 290.82 Million | 284.37 Million | 31.74 Million | -14.38 Million | 4.3 Billion |
| Stock-based compensation | - | -290.82 Million | -284.37 Million | -31.74 Million | 14.38 Million | 1.93 Billion |
| Change in working capital | 8.61 Billion | 3.74 Billion | 8.35 Billion | -2.33 Billion | -242.63 Million | -5 Billion |
| Other non-cash items | 34.63 Billion | 4.87 Billion | -1.88 Billion | 1.04 Billion | 3.17 Billion | 2.09 Billion |
| Investing Cash Flow | 25.89 Billion | 8.05 Billion | -146.39 Billion | -44.3 Billion | 10.47 Billion | -8 Billion |
| Investments in PPE | -5.65 Billion | -45.4 Billion | -82.51 Billion | -16.37 Billion | -3 Billion | -3.64 Billion |
| Acquisitions | 15.7 Million | - | -994.59 Million | 216.59 Million | -172.72 Million | 97.28 Million |
| Investment purchases | -67.47 Billion | -271.62 Billion | -133 Billion | -151.41 Billion | -30.71 Billion | -4.07 Billion |
| Sales/Maturities of investments | 99 Billion | 324.62 Billion | 76 Billion | 123.87 Billion | 44.19 Billion | 67.72 Million |
| Other Investing Activities | -1.00 | 463.13 Million | -5.88 Billion | -616.22 Million | 172.72 Million | -462 Million |
| Financing Cash Flow | -8.28 Billion | 7.01 Billion | 111.02 Billion | 106.23 Billion | -656.99 Million | 11.6 Billion |
| Debt repayment | -8.42 Billion | -3.54 Billion | -150.86 Million | -10.49 Billion | -2.6 Billion | -152.23 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -2.96 Million | -15.57 Million | - | -856.15 Thousand | - |
| Common Stock Issuance | 2.46 Billion | 382.44 Million | 112.6 Billion | 94.4 Billion | 2.94 Billion | - |
| Other Financing Activities | -5.64 Million | 10.17 Billion | -1.4 Billion | 22.32 Billion | -992.28 Million | 11.76 Billion |
| Accounts receivables | 5.53 Billion | 414.8 Million | 1.09 Billion | 1.88 Billion | -1.76 Billion | -3.39 Billion |
| Accounts payables | 3.8 Billion | -10 Billion | 10.6 Billion | 4.52 Billion | 747.34 Million | -765.9 Million |
| Inventory | -207.62 Million | -4.25 Billion | -2.41 Billion | 409.54 Million | -933.06 Million | -949.23 Million |
| Other working capital | -510.39 Million | 17.58 Billion | -932.09 Million | -9.16 Billion | 1.7 Billion | -4.05 Billion |
| Cash at beginning of period | 13.26 Billion | 22.3 Billion | 62.43 Billion | 16.92 Billion | 8.37 Billion | 12.02 Billion |
| Cash at end of period | 9.11 Billion | 13.26 Billion | 22.3 Billion | 62.43 Billion | 16.92 Billion | 8.37 Billion |
| Capital Expenditure | -5.65 Billion | -45.4 Billion | -82.51 Billion | -16.37 Billion | -3 Billion | -3.64 Billion |
| Effect of forex changes on cash | -13.28 Million | -3.42 Million | 101.36 Million | -503.35 Million | -625.66 Thousand | 27.88 Million |
| Net cash flow / Change in cash | -4.15 Billion | -9.04 Billion | -40.12 Billion | 45.51 Billion | 8.54 Billion | -3.64 Billion |
| Free Cash Flow | -27.39 Billion | -69.52 Billion | -87.36 Billion | -32.28 Billion | -4.27 Billion | -10.91 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -12.8 Billion | -9.48 Billion | -39.8 Billion | -77.76 Billion | -11.55 Billion | -13.19 Billion |
| Depreciation & Amortization | 4.57 Billion | 4.48 Billion | 4.12 Billion | 12.77 Billion | 4.42 Billion | 2.87 Billion |
| Deferred income taxes | - | - | -9.32 Million | - | 9.32 Million | - |
| Stock-based compensation | - | - | -8.14 Billion | - | -9.32 Million | - |
| Change in working capital | 826.92 Million | -1.16 Billion | -1.97 Billion | 8.61 Billion | 6.4 Billion | 4.3 Billion |
| Other non-cash items | 1.63 Billion | 1.63 Billion | 41.65 Billion | 34.63 Billion | 150.23 Million | -571.29 Million |
| Investing Cash Flow | -2.09 Billion | 397.98 Million | 1.42 Billion | 25.89 Billion | 1.39 Billion | 9.83 Billion |
| Investments in PPE | -663.52 Million | -72.81 Million | -2.96 Billion | -5.65 Billion | -120.14 Million | -1.79 Billion |
| Acquisitions | - | - | - | 15.7 Million | 33.23 Million | 58.5 Million |
| Investment purchases | -4.6 Billion | - | 4.37 Billion | -67.47 Billion | -2.49 Billion | -19.35 Billion |
| Sales/Maturities of investments | 3.16 Billion | 470.79 Million | - | 99 Billion | 4 Billion | 31 Billion |
| Other Investing Activities | -1.43 Billion | 10.00 | 14.04 Million | -1.00 | -24.61 Million | -81.16 Million |
| Financing Cash Flow | 2.23 Billion | 4.55 Billion | 5.05 Billion | -8.28 Billion | 3.82 Billion | -13.59 Billion |
| Debt repayment | -2.12 Billion | -1.55 Billion | -5.59 Billion | -8.42 Billion | -1.96 Billion | -13 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 3.58 Billion | - | 2.46 Billion | 2.46 Billion | - |
| Other Financing Activities | 107.42 Million | - | 10.00 | -5.64 Million | 3.33 Billion | -591.63 Million |
| Accounts receivables | -3.99 Billion | 4.59 Billion | -11.74 Million | 5.53 Billion | 7.76 Billion | -1.04 Billion |
| Accounts payables | 73.41 Million | 3.57 Billion | -510.34 Million | 3.8 Billion | 2.39 Billion | 313.75 Million |
| Inventory | -741.68 Million | -1.04 Billion | 631.27 Million | -207.62 Million | 497.89 Million | -186.02 Million |
| Other working capital | 5.56 Billion | -8.3 Billion | -2.08 Billion | -510.39 Million | -4.25 Billion | 5.22 Billion |
| Cash at beginning of period | 7.7 Billion | 9.11 Billion | 6.8 Billion | 13.26 Billion | 2.16 Billion | 12.5 Billion |
| Cash at end of period | 2.06 Billion | 7.7 Billion | 9.11 Billion | 9.11 Billion | 6.8 Billion | 2.16 Billion |
| Capital Expenditure | -663.52 Million | -72.81 Million | -2.96 Billion | -5.65 Billion | -120.14 Million | -1.79 Billion |
| Effect of forex changes on cash | 2.13 Million | 4.49 Million | -20.26 Million | -13.28 Million | -3.67 Million | 8.54 Million |
| Net cash flow / Change in cash | -5.63 Billion | -1.41 Billion | 2.3 Billion | -4.15 Billion | 4.64 Billion | -10.34 Billion |
| Free Cash Flow | -6.43 Billion | -6.43 Billion | -7.12 Billion | -27.39 Billion | -699.1 Million | -8.37 Billion |
SRGHFL
004800
CIG
MAMO
ALCO
REH